Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
The cuprizone model: regional heterogeneity of pathology.
Remyelination Therapy for Multiple Sclerosis.
Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study.
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Arterial, venous and other vascular risk factors in multiple sclerosis.
Pathogenic CD8 T cells in multiple sclerosis and its experimental models.
On the Epidemiology of Multiple Sclerosis in the Middle East and North Africa.
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
Development of a high-resolution fat and CSFsuppressed optic nerve DTI protocol at 3T: application in multiple sclerosis.
Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
Network Analysis of Randomized Controlled Trials in Multiple Sclerosis.
Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability.
Bupropion-Related Visual Hallucinations in a Veteran With Posttraumatic Stress Disorder and Multiple Sclerosis.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Pages
« first
‹ previous
…
217
218
219
220
221
222
223
224
225
…
next ›
last »